Anocca announces authorisation pancreatic cancer trial - PharmaTimes VIDAR-1 trial marks company's clinical-stage debut

#Anocca #pancreaticcancer #VIDAR1trial #VIDAR1programme#KRASpositiveadvancedpancreaticcancer #ANOC001therapy #KRASG12Vmutation #TCRTcellsolution #nonviralgeneeditedtreatment #pancreaticcancerpatients #oncogenicKRASmutations #pancreaticductaladenocarcinoma
pharmatimes.com/news/anocca-...